Breaking News

Vetter recognised with Global Customer Value Leadership Award

The Frost and Sullivan decision process involved three major steps

Fujifilm confirms £400m investment plans at UK biopharma site

The additional facilities are expected to be operational by late 2023

Leucid Bio chooses Lonza automated personalised CAR T-Cells platform

Leucid will utilise Lonza as its preferred manufacturer, aiming to deliver high quality cell therapies quickly and cost- ...

CBD: the new frontier in medical science

Early stage drug development plays an important role in expanding treatment options that will support the health of ...

CordenPharma invests in green purification for complex lipids

CordenPharma has invested in an expansion of its speciality lipids production at CordenPharma Chenôve (FR) using ...

Sterling announces partnership with University of Manchester

The company will provide scale-up and process development expertise for the manufacture of molnupiravir, a COVID-19 ...

Driving biotherapeutic development with advanced molecule characterisation

Evaluating and characterising complicated protein structures and the therapeutic activity of advanced biotherapeutic ...

Adare Pharma Solutions makes contract manufacturing acquisition

Adare has acquired Frontida BioPharm that is a vertically integrated CDMO focused on oral formulations

SGS opens testing laboratory in Qingdao

The laboratory’s 45 employees provide a range of direct services with rapid turnaround times

Advances in technology and support for Direct-To-Patient (DTP) services

Although the emergence of COVID-19 has led to an industry wide uptake of decentralised clinical trial models — ...

The new regulatory world for medical devices

Establishing an effective compliance strategy now ahead of the 2022 IVDR legislation is critical — because there’s ...

Nitrosamine testing: the regulatory aspects

Subsequent to the detection of nitrosamines in pharmaceuticals in 2018, this class of impurities has been a pressing ...

Sanofi to acquire Origimm Biotechnology

The acquisition is part of Sanofi's goal to treat acne with vaccine-based immunotherapy

Lonza and signs agreement with VC for molecule development

Lonza's expertise and technology is hoped to accelerates timelines while mitigating risks of the development and ...

Inspiration and Learning

People

Reports